Find out what Breast Cancer Care is saying about the latest drug treatments, research papers and health policy issues.

If you’re a journalist working on a story and need an expert quote, call us on 0345 092 0807 (out of hours 07702 901 334).

Responding to a new study, published in the journal Clinical Chemistry, that suggests the prospect of further personalisation of treatment for...

27 July 2017

Responding to the Cancer Patient Experience Survey, released today, David Crosby, Director of Services and Engagement at Breast Cancer Care, says...

21 July 2017

Responding to a new study that suggests menopausal symptoms often linked to tamoxifen* also occurred when women were taking a placebo drug, Carolyn...

30 June 2017

Responding to the latest ONS one and five-year survival figures, and the predicted 10-year survival figures for breast cancer in England, Gunes...

29 June 2017

Responding to the decision from NICE, announced today (Thursday 15 June), that trastuzumab emtansine (Kadcyla)* is approved for use on the NHS in...

15 June 2017

Responding to the decision from NICE announced today (Thursday 15 June) that trastuzumab emtansine (Kadcyla)* is approved for use on the NHS in...

15 June 2017

Responding to the Scottish Medicines Consortium decision that pertuzumab (Perjeta)* in combination with two other treatments - trastuzumab and...

12 June 2017

Responding to expert comment from the American Society of Clinical Oncology conference in Chicago - suggesting that three-quarters of cancer patients...

7 June 2017

Responding to research presented at the American Society of Clinical Oncology conference in Chicago - suggesting that yoga may help to improve cancer...

7 June 2017